Floatz logo

Fludarabine

Recurrent Childhood Acute Myeloid Leukemia

Joanna YiSmall moleculePhase 3Active
BB
70/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
65/ 100
Competitive Position
81/ 100

Competitive context

13 Active assets in the Recurrent Childhood Acute Myeloid Leukemia cohort.

Asset / SponsorPhaseRating
ETOPOSIDE
Joanna Yi
Phase 3BBB
FILGRASTIM
Washington University School of Medicine
Phase 3BB
Cyclophosphamide
Joanna Yi
Phase 3BB
Romidepsin
Washington University School of Medicine
Phase 3BB
Cediranib
National Cancer Institute (NCI)
Phase 3BB

View all 43 →

Same molecule, other indications

Fludarabine is also rated in:

acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant
BBB
Indicative ·
76 / 100
View asset →
Fanconi anemiaDormant
BBB
Indicative ·
76 / 100
View asset →
Recurrent Adult Diffuse Large Cell LymphomaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →